2027: ABIA APC GOV CANDIDATE UNVEILS RUNNING MATE. (PHOTO).

Image
 2027: Abia APC gov candidate unveils running mate The All Progressives Congress governorship candidate in the 2027 general election in Abia State, Eric Opah, presented his running mate, Godswill Egbe, to the party in the state, noting that the party is running to win. Opah made the presentation on Monday in Umuahia, the state capital. “If you want to choose somebody to work with, you have to make sure that it is not somebody who will give you trouble. So, because running mate and deputy governor positions often come with disagreements with the principal, I took my time. I have to tell our party members, this is a man of integrity,” Opah said. He added that Egbe is a man that Abians and the APC will be proud of. “Let me make it very clear. We are running this election. APC is running this election to win. “Agu Egbe will work with me in honesty to use Abia money to work for Abians. We are not going to claim 400 roads when we build 20. We are going to ensure that we create jobs for A...

ZIMBABWE ROLLS OUT NEW HIV PREVENTION DRUG LENACAPAVIR. (PHOTO)


 Zimbabwe rolls out new HIV prevention drug lenacapavir


Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections.


Health Minister Douglas Mombeshora said the programme, funded by the U.S. and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.


"Today marks an important day in Zimbabwe's national response to HIV. We gather here to launch lenacapavir - a long-acting injectable option for HIV prevention - and to show our commitment to protecting life and ending AIDS as a public health threat," Mombeshora said, Reuters reported.


He said Zimbabwe received its first batch and injected some early adopters earlier this month, adding that the rollout would be done in phases.


Significant progress


Lenacapavir, developed by Gilead Sciences, is administered as a subcutaneous injection twice a year. Officials say it could help overcome adherence challenges associated with daily oral pre-exposure prophylaxis (PrEP) pills.


Zimbabwe has made significant progress in tackling HIV, achieving the 95-95-95 treatment targets set by U.N. programme UNAIDS — meaning 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those on treatment have suppressed viral loads.


Melody Dengu, a community leader in the Harare suburb of Epworth, said she had already received the jab earlier this month.


"I have also (so far) gotten 12 other people to come and get injected," she told Reuters at the event.


Zimbabwe has one of Africa's highest HIV burdens, though new infections have declined significantly over the past decade due to expanded testing, treatment and prevention.

Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.